- February 20, 2026
-
-
Loading
Loading
OLDSMAR — Patients with degenerative diseases such as Parkinson's or Huntington's disease, or multiple sclerosis, may potentially benefit from a new patent issued to Saneron CCEL Therapeutics Inc. and the University of South Florida. The patent covers a method that may enable increased use of cord blood stem cells in medical therapies, according to a Saneron investor.
